Margarita Anders

1.5k total citations
36 papers, 448 citations indexed

About

Margarita Anders is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Margarita Anders has authored 36 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 22 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Margarita Anders's work include Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (13 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Margarita Anders is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (13 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). Margarita Anders collaborates with scholars based in Argentina, Brazil and Colombia. Margarita Anders's co-authors include Ricardo Mastaï, Lucas McCormack, Sebastián Marciano, Adrián Gadano, Marcelo Silva, Nicolás Goldaracena, Alina Zerega, Manuel Mendizábal, Federico Piñero and Silvina Yantorno and has published in prestigious journals such as SHILAP Revista de lepidopterología, Transplantation and Vaccine.

In The Last Decade

Margarita Anders

34 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margarita Anders Argentina 13 275 273 139 85 52 36 448
Jonas Schreiber Belgium 8 114 0.4× 132 0.5× 26 0.2× 117 1.4× 33 0.6× 10 262
Rehab Badawi Egypt 13 222 0.8× 230 0.8× 74 0.5× 17 0.2× 17 0.3× 45 442
Alexander Queck Germany 9 214 0.8× 275 1.0× 91 0.7× 14 0.2× 35 0.7× 25 386
Mona S. El‐Raziky Egypt 15 299 1.1× 353 1.3× 75 0.5× 22 0.3× 6 0.1× 45 604
Nazish Butt Pakistan 10 140 0.5× 169 0.6× 42 0.3× 90 1.1× 10 0.2× 39 325
Rajesh Rajalingam India 11 116 0.4× 69 0.3× 169 1.2× 34 0.4× 16 0.3× 43 320
Karl Esrason United States 7 305 1.1× 223 0.8× 191 1.4× 43 0.5× 41 0.8× 7 451
Irene Vafiadis Greece 9 235 0.9× 246 0.9× 128 0.9× 24 0.3× 26 0.5× 11 379
Carol Goulding Ireland 9 139 0.5× 152 0.6× 63 0.5× 30 0.4× 63 1.2× 15 434
Andrew D. Yeoman United Kingdom 7 595 2.2× 517 1.9× 168 1.2× 94 1.1× 50 1.0× 10 702

Countries citing papers authored by Margarita Anders

Since Specialization
Citations

This map shows the geographic impact of Margarita Anders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margarita Anders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margarita Anders more than expected).

Fields of papers citing papers by Margarita Anders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margarita Anders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margarita Anders. The network helps show where Margarita Anders may publish in the future.

Co-authorship network of co-authors of Margarita Anders

This figure shows the co-authorship network connecting the top 25 collaborators of Margarita Anders. A scholar is included among the top collaborators of Margarita Anders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margarita Anders. Margarita Anders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fonseca, Leonardo Gomes da, Federico Piñero, Margarita Anders, et al.. (2025). Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma. Oncotarget. 16(1). 348–360.
2.
Mauro, Ezequiel, et al.. (2023). Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients. Vaccine. 41(52). 7663–7670. 1 indexed citations
3.
4.
Marín, Juan Ignacio, et al.. (2023). The leading and key role of hepatologists in the multidisciplinary management of patients with hepatocellular carcinoma. Annals of Hepatology. 28(4). 101112–101112. 2 indexed citations
5.
Marciano, Sebastián, Leila Haddad, Paola Casciato, et al.. (2021). Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype. Metabolomics. 17(7). 58–58. 15 indexed citations
6.
Fabrizi, Fabrizio, Cristina Alonso, Margarita Anders, et al.. (2021). ‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant. Annals of Hepatology. 25. 100337–100337. 3 indexed citations
7.
Mendizábal, Manuel, Leila Haddad, Sebastián Marciano, et al.. (2020). Hepatitis E infection is an infrequent cause of acute hepatitis in the metropolitan area of Buenos Aires. Journal of Clinical Virology. 126. 104309–104309. 3 indexed citations
8.
Piñero, Federico, Sebastián Marciano, Nora Fernández, et al.. (2019). Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis. World Journal of Gastroenterology. 25(27). 3607–3618. 11 indexed citations
9.
Mendizábal, Manuel, Fernando Rubinstein, Sebastián Marciano, et al.. (2019). Liver transplantation in adults with acute liver failure: Outcomes from the Argentinean Transplant Registry. Annals of Hepatology. 18(2). 338–344. 16 indexed citations
10.
Piñero, Federico, Sebastián Marciano, Nora Fernández, et al.. (2018). Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina. World Journal of Hepatology. 10(1). 41–50. 36 indexed citations
11.
Piñero, Federico, Sebastián Marciano, Margarita Anders, et al.. (2016). Sorafenib for recurrent hepatocellular carcinoma after liver transplantation: a South American experience. Redalyc (Universidad Autónoma del Estado de México). 46(4). 3 indexed citations
12.
Piñero, Federico, Sebastián Marciano, Margarita Anders, et al.. (2015). Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina. European Journal of Gastroenterology & Hepatology. 28(4). 421–427. 18 indexed citations
13.
Mendizábal, Manuel, Sebastián Marciano, Margarita Anders, et al.. (2015). Fulminant presentation of autoimmune hepatitis. European Journal of Gastroenterology & Hepatology. 27(6). 644–648. 39 indexed citations
14.
Piñero, Federico, Sebastián Marciano, Margarita Anders, et al.. (2015). Screening for liver cancer during transplant waiting list. European Journal of Gastroenterology & Hepatology. 27(3). 355–360. 8 indexed citations
15.
Mendizábal, Manuel, Sebastián Marciano, Margarita Anders, et al.. (2014). Changing etiologies and outcomes of acute liver failure: Perspectives from 6 transplant centers in Argentina. Liver Transplantation. 20(4). 483–489. 26 indexed citations
16.
Cura, Carolina, R. Lattes, Claudia Nagel, et al.. (2013). Early Molecular Diagnosis of Acute Chagas Disease After Transplantation With Organs From Trypanosoma cruzi–Infected Donors. American Journal of Transplantation. 13(12). 3253–3261. 37 indexed citations
17.
Marciano, Sebastián, Valeria Descalzi, Silvina Yantorno, et al.. (2013). Use of Liver Grafts From Anti-Hepatitis B Core-Positive Donors: A Multicenter Study in Argentina. Transplantation Proceedings. 45(4). 1331–1334. 3 indexed citations
18.
Goldaracena, Nicolás, et al.. (2012). Extremely Marginal Liver Grafts From Deceased Donors Have Outcome Similar to Ideal Grafts. Transplantation Proceedings. 44(7). 2219–2222. 23 indexed citations
19.
20.
McCormack, Lucas, Nicolás Goldaracena, Margarita Anders, et al.. (2010). Rescue policy for discarded liver grafts: a single-centre experience of transplanting livers ‘that nobody wants’. HPB. 12(8). 523–530. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonas Schreiber Breakdown of academic impact, for papers by Rehab Badawi Breakdown of academic impact, for papers by Alexander Queck Breakdown of academic impact, for papers by Mona S. El‐Raziky Breakdown of academic impact, for papers by Nazish Butt Breakdown of academic impact, for papers by Rajesh Rajalingam Breakdown of academic impact, for papers by Karl Esrason Breakdown of academic impact, for papers by Irene Vafiadis Breakdown of academic impact, for papers by Carol Goulding Breakdown of academic impact, for papers by Andrew D. Yeoman
Rankless by CCL
2026